Hepatitis C virus reinfection was common in five Australian prisons, a study found — especially among injection drug users, highlighting the need for post-treatment surveillance and increased services, researchers said.
Research has shown that HCV is prevalent in United States prisons, with around 30% of the country’s HCV-infected people passing through the prison system each year. Universal HCV testing and treatment programs in prisons have been shown to be “cost-effective, but costly,” with high cure rates.
The prisons in the Australian study all had opioid agonist